Repeated administration with δ9- tetrahydrocannabinol regulates µ-opioid receptor density in the rat brain
- 1 March 2004
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 18 (1) , 54-58
- https://doi.org/10.1177/0269881104040237
Abstract
Several studies have demonstrated reciprocal, as well as synergistic interactions between cannabinoid and opioid systems. The aim of this study was to explore the time-related effects of repeated administration of δ9-tetrahydrocannabinol on µ-opioid receptor autoradiography in various brain regions of the rat. To this aim, the effects of δ9-tetrahydrocannabinol (δ9-THC, 5 mg/kg/day; i.p.) were examined after 1, 3, 7 and 14 days of repeated administration on regions containing µ-opioid receptors: (i) forebrain [caudate-putamen, nucleus accumbens (core and shell) and piriform cortex]; (ii) amygdala (medial pars and cortical posteromedial pars), hypothalamus (ventromedial and dorsomedial nuclei, zona incerta), hippocampal regions (CA1, CA2, CA3, dentate girus), hindbrain (substantia nigra and ventral tegmental area); and (iii) thalamus, including 12 thalamic nuclei. In most of these regions, repeated cannabinoid administration increases µ-opioid receptor density; however, the onset, degree of magnitude reached and time-related effects produced by administration with δ9-tetrahydrocannabinol are dependent upon the brain region examined. It appears that the major increase in µ-opioid receptor density occurs 1 and 3 days after δ9-THC administration. In some regions, this increase is maintained and, for most of the brain areas examined, this effect is no longer significant by 14 days of administration, suggesting tolerance to cannabinoid treatment. Taken together, the results of this study suggest that cannabinoids produce a time-related differential responsiveness in µ-opioid receptor density in several brain areas that may be relevant to an understanding of the alterations associated with cannabinoid exposure.Keywords
This publication has 17 references indexed in Scilit:
- Endocannabinoids in the central nervous system-an overviewProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in ratsNeuroscience Letters, 2000
- Inhibition of Calcium/Calmodulin-Dependent Protein Kinase II in Rat Hippocampus Attenuates Morphine Tolerance and DependenceMolecular Pharmacology, 1999
- Pharmacological and biochemical interactions between opioids and cannabinoidsTrends in Pharmacological Sciences, 1999
- Time-dependent differences of repeated administration with Δ9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by μ-opioid and CB1-cannabinoid receptors in the caudate–putamenMolecular Brain Research, 1999
- Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjectionsBrain Research, 1999
- An analgesia circuit activated by cannabinoidsNature, 1998
- Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive miceNeuroscience, 1998
- Naloxone-induced or postwithdrawal abstinence signs in ?9-Tetrahydrocannabinol-Tolerant ratsPsychopharmacology, 1977
- Interactions between cannabidiol and Δ9-THC during abstinence in morphine-dependent ratsLife Sciences, 1975